| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0369-8114(03)00016-6 |
| P698 | PubMed publication ID | 12781800 |
| P2093 | author name string | J Santini | |
| H Raybaud | |||
| R A Monteil | |||
| A Fafet | |||
| G Odin | |||
| P2860 | cites work | PUMA, a novel proapoptotic gene, is induced by p53 | Q24291463 |
| A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 | Q24322196 | ||
| The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53 | Q28266637 | ||
| The RNA component of human telomerase | Q28288330 | ||
| Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. | Q28590239 | ||
| Cancer. p53, guardian of the genome | Q29615610 | ||
| Ras mutations in United Kingdom examples of oral malignancies are infrequent | Q33560032 | ||
| New Myc-interacting proteins: a second Myc network emerges | Q33667300 | ||
| Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx | Q33709475 | ||
| The Bcl-2 protein family | Q33876776 | ||
| Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. | Q33890659 | ||
| p53: death star | Q34103258 | ||
| Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck | Q36081853 | ||
| p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients < 35 versus > 75 years. | Q38466090 | ||
| Cell cycle proteins and the development of oral squamous cell carcinoma. | Q38466264 | ||
| Point mutations in the Ha-ras oncogene are detectable in formalin-fixed tissues of oral squamous cell carcinomas, but are infrequent in British cases | Q38487660 | ||
| Molecular lesions in human oral cancer: the Indian scene | Q40622702 | ||
| Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis | Q40775185 | ||
| Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma | Q40776709 | ||
| Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck | Q40893232 | ||
| Telomerase activity in oral squamous cell carcinoma | Q41022653 | ||
| p53 overexpression in head and neck squamous cell carcinoma: review of the literature | Q41077872 | ||
| Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma | Q42457159 | ||
| Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status | Q42465631 | ||
| Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance | Q42511030 | ||
| Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity | Q42529193 | ||
| p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation | Q42536360 | ||
| Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology | Q43609590 | ||
| Immunohistochemical detection of the H-ras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck | Q46306270 | ||
| Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. | Q47820459 | ||
| Cyclin D1 overexpression associates with radiosensitivity in oral squamous cell carcinoma. | Q52833131 | ||
| Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma. | Q52967092 | ||
| MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis. | Q53409324 | ||
| Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India. | Q53429879 | ||
| c-myc oncogene copy number in squamous carcinoma of the head and neck. | Q53790779 | ||
| Involvement of the bcl-2 gene in human follicular lymphoma | Q69870224 | ||
| p53 and MDM2 expression in oral squamous cell carcinoma | Q71221193 | ||
| Alterations of p16/CDKN2, p53 and ras genes in oral squamous cell carcinomas and premalignant lesions | Q71603626 | ||
| Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinoma in Taiwan | Q71750708 | ||
| The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer | Q71771624 | ||
| Absence of retinoblastoma gene product in human primary oral cavity carcinomas | Q71836757 | ||
| Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications | Q73006549 | ||
| Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression | Q73016393 | ||
| Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study | Q73132173 | ||
| Telomerase activity in oral cancer | Q73326289 | ||
| Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck | Q73353859 | ||
| Evaluation of telomerase activation in head and neck cancer | Q73493353 | ||
| p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx | Q73794408 | ||
| ras gene mutations in oral cancer in eastern India | Q73979645 | ||
| Diffuse mode of tumor cell invasion and expression of mutant p53 protein but not of p21 protein are correlated with treatment failure in oral carcinomas and their metastatic foci | Q74001284 | ||
| p53, but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use | Q74390453 | ||
| RB regulates the stability and the apoptotic function of p53 via MDM2 | Q74607074 | ||
| Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma | Q77296291 | ||
| Localization of Fas antigen in oral squamous cell carcinoma | Q77324519 | ||
| DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas | Q77377735 | ||
| Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan | Q77424779 | ||
| p53 and Ki-67 as markers of radioresistance in head and neck carcinoma | Q77666711 | ||
| pRb and p16 protein alterations in human oral tumorigenesis | Q77711753 | ||
| Expression of p53 and p21 proteins in oral squamous cell carcinoma: correlation with lymph node metastasis and response to chemoradiotherapy | Q77811302 | ||
| Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma | Q77889745 | ||
| An analysis of the prognostic significance of p53 status for squamous cell carcinoma of the oral cavity treated by radiotherapy | Q77942716 | ||
| Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma | Q77994230 | ||
| MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications | Q78092341 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | French | Q150 |
| P304 | page(s) | 176-184 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | Pathology and Biology | Q15750340 |
| P1476 | title | [Genic alterations in oral and head and neck squamous cell carcinomas: analysis of international literature]. | |
| P478 | volume | 51 |
Search more.